These effects, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 help the notion of targeting ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Ailments.Depending on readily available science the Conolidine